The importance of ethnicity in the diagnosis and prognosis of sarcoidosis

Chest

Volumn 111, Issue 4, 1997, Pages 838-840

  Israel, H L ^a   Gottlieb, J A ^a   Peters, S P ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

BRONCHUS BIOPSY; DIAGNOSTIC VALUE; EDITORIAL; ETHNIC DIFFERENCE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROGNOSIS; RACE DIFFERENCE; SARCOIDOSIS; STEROID THERAPY;

EID: 0030974975     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.111.4.838     Document Type: Editorial

References (21)

1. Torrington KG Parker JM Shorr AF. Endobronchial disease and racial differences in pulmonary sarcoidosis Chest 111 1997 619 622
2. Armstrong JR Radke JR Eichenhorn MS Endoscopic findings in sarcoidosis: characteristics and correlations with radiographic staging and bronchial mucosal biopsy yield Ann Otolaryngol 90 1981 339 343
3. Stjernberg N Bjornstad-Pettersen H Truedsson H. Flexible fiberoptic bronchoscopy in sarcoidosis Acta Med Scand 208 1980 397 399
4. Bjermer L Thunell M Rosenhall L Endobronchial biopsy positive sarcoidosis: relationship to bronchoalveolar lavage and course of disease Respir Med 85 1991 229 234
5. Israel HL Karlin P Menduke H Factors affecting outcome of sarcoidosis: influence of race, extrathoracic involvement and initial radiologic lung lesions Ann NY Acad Sci 465 1986 609 618
6. Morgan TO Jacobsen SJ McCarthy WF Age-specific reference ranges for serum prostate-specific antigen in black men N Engl J Med 335 1996 304 310
7. Brancati FL Whelton PK Kuller LH Diabetes mellitus, race and socioeconomic status: a population based study Ann Epidemiol 6 1996 67 73
8. Johnson JA Burlew BS Stiles RN. Racial differences in β-adrenoceptor-mediated responsiveness J Cardiovasc Pharmacol 25 1995 90 96
9. DeRemee RA. Sarcoidosis. Mayo Clin Proc 70 1995 177 181
10. Israel HL Fouts DW Beggs RA. A controlled trial of prednisone treatment of sarcoidosis Am Rev Respir Dis 107 1973 609 614
11. Gottlieb JE Israel HL Steiner RM Outcome in sarcoidosis: the relationship of relapse to corticosteroid therapy Chest 111 1997 623 631
12. Selroos O Sellergren TL. Corticosteroid therapy of pulmonary sarcoidosis. A prospective evaluation of alternate day and daily dosage in stage II disease Scand J Respir Dis 60 1979 215 221
13. Yamamoto M Saito N Tachibana T Effects of 18-month corticosteroid therapy on stage I and stage II sarcoidosis patients (a control trial) Chretien J Marsac J Saltiel JC Sarcoidosis and other granulomatous disorders 1983 Pergamon Press Paris 470 474
14. Hakerload LE Young RL Savage PJ Pulmonary sarcoidosis: long-term follow-up of the effects of steroid therapy Chest 82 1982 84 87
15. Eule H Weinecke A Roth I. The possible influence of corticoidsteroid therapy on the natural course of pulmonary sarcoidosis: late results of a continuing clinical study Ann NY Acad Sci 465 1986 695 701
16. Zaki MH Lyons HA Leilop L Corticosteroid therapy in sarcoidosis: a five year, controlled, follow-up study NY State J Med 87 1987 496 499
17. Gibson GJ Prescott RJ Muers MF British Thoracic Society sarcoidosis study: effects of long term corticosteroid treatment Thorax 51 1996 238 247
18. du Bois RM. Corticosteroids in sarcoidosis: friend or foe? Eur Respir J 7 1994 1203 1209
19. Israel HL. Corticosteroid treatment of sarcoidosis—who needs it? NY State J Med 87 1987 490
20. Izumi T. Are corticosteroids harmful to sarcoidosis—a conclusion drawn from a retrospective study on the chest radiographic prognosis of 185 asymptomatic patients with pulmonary sarcoidosis followed up for more than ten years Sarcoidosis 11 Suppl l 1994 119 122
21. Haslam PL. Clinical evaluation of different markers of inflammation in relation to disease activity, and long-term outcome in pulmonary sarcoidosis Sarcoidosis 9 suppl l 1992 37 42